Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongze Liu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Genetics|August 1, 2022
Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell CarcinomaShengxian Xu, Dongze Liu, Taihao Chang, et al.
Journal of Pharmaceutical Analysis|May 27, 2026
The role of NRF2 in human cancers: Pre-clinical insights paving the way for clinical trialsYi Pei, Jianqiao Yin, Jiamei Liu, et al.
Scientific Reports|December 9, 2022
Pan-cancer analysis of the prognostic and immunological role of PAQR4Kaibin Wang, Jinhuan Meng, Xudong Wang, et al.
Frontiers in Oncology|June 30, 2023
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapyHongtuan Zhang, Dongze Liu, Zheng Qin, et al.
Aging|December 26, 2023
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancerShengxian Xu, Dongze Liu, Zheng Qin, et al.
Oncology Research|April 3, 2026
OTUD4 Inhibits Prostate Cancer by Deubiquitinating MYH9Zheng Qin, Yueyao Zhang, Dongze Liu, et al.
Frontiers in Immunology|July 25, 2025
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysisBo Han, Weiyang Liu, Wanhui Wang, et al.
Biology Direct|March 26, 2026
In-silico study of machine learning discovers de novo lipogenesis for predicting prognosis and immunotherapy responses in kidney renal clear cell carcinomaDongze Liu, Weiyang Liu, Bo Han, et al.
Cancer Research|February 11, 2026
Tumor-Resident Streptococcus pneumoniae Promotes Malignant Progression and Pazopanib Resistance in Clear Cell Renal Cell CarcinomaJinpeng Wang, Yunfeng Nan, Qing Liu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Genetics|August 1, 2022
Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell CarcinomaShengxian Xu, Dongze Liu, Taihao Chang, et al.
Journal of Pharmaceutical Analysis|May 27, 2026
The role of NRF2 in human cancers: Pre-clinical insights paving the way for clinical trialsYi Pei, Jianqiao Yin, Jiamei Liu, et al.
Scientific Reports|December 9, 2022
Pan-cancer analysis of the prognostic and immunological role of PAQR4Kaibin Wang, Jinhuan Meng, Xudong Wang, et al.
Frontiers in Oncology|June 30, 2023
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapyHongtuan Zhang, Dongze Liu, Zheng Qin, et al.
Aging|December 26, 2023
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancerShengxian Xu, Dongze Liu, Zheng Qin, et al.
Oncology Research|April 3, 2026
OTUD4 Inhibits Prostate Cancer by Deubiquitinating MYH9Zheng Qin, Yueyao Zhang, Dongze Liu, et al.
Frontiers in Immunology|July 25, 2025
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysisBo Han, Weiyang Liu, Wanhui Wang, et al.
Biology Direct|March 26, 2026
In-silico study of machine learning discovers de novo lipogenesis for predicting prognosis and immunotherapy responses in kidney renal clear cell carcinomaDongze Liu, Weiyang Liu, Bo Han, et al.
Cancer Research|February 11, 2026
Tumor-Resident Streptococcus pneumoniae Promotes Malignant Progression and Pazopanib Resistance in Clear Cell Renal Cell CarcinomaJinpeng Wang, Yunfeng Nan, Qing Liu, et al.
Pageof 2